EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study

Naoum P Issa iD, Serdar Aydin iD, Eric Polley, Nathan Carberry, Mark A Garret iD, Sean Smith, Ali A Habib iD, Nicholas W Baumgartner iD, Betty Soliven, Kourosh Rezania

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0303053 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Naoum P Issa und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Chicago Medical Center, Chicago, IL, United States of America. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Biomarkers, Electromyography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the protocol of a prospective study to test the validity of intermuscular coherence (IMC) as a diagnostic tool and biomarker of upper motor neuron degeneration in amyotrophic lateral sclerosis (ALS).

Methods

This is a multicenter, prospective study. IMC of muscle pairs in the upper and lower limbs is gathered in ∼650 subjects across three groups using surface electrodes and conventional electromyography (EMG) machines. The following subjects will be tested: 1) neurotypical controls; 2) patients with symptomatology suggestive for early ALS but not meeting probable or definite ALS by Awaji Criteria; 3) patients with a known ALS mimic. The recruitment period is between 3/31/2021 and 12/31/2025. Written consent will be sought from the subject or the subject’s legally authorized representative during enrollment.

Results

The endpoints of this study include: 1) whether adding IMC to the Awaji ALS criteria improve its sensitivity in early ALS and can allow for diagnosis earlier; 2) constructing a database of IMC across different ages, genders, and ethnicities. Significance This study may validate a new inexpensive, painless, and widely available tool for the diagnosis of ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisBiomarkersElectromyographyAdultAgedFemaleHumansMaleMiddle AgedMotor NeuronsMuscle, SkeletalProspective StudiesMulticenter Studies as Topic

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University of Chicago Medical Center, Chicago, IL, United States of America.
  • University of Miami, Coral Gables, FL, United States of America.
  • Massachusetts General Hospital, Boston, MA, United States of America.
  • Washington University, St. Louis, MO, United States of America.
  • University of California, Irvine, Irvine, CA, United States of America.
  • Rush University Medical Center, Chicago, IL, United States of America.

ORCID-Profile: Naoum P Issa, Serdar Aydin, Mark A Garret, Ali A Habib, Nicholas W Baumgartner

Förderung

  • NINDS NIH HHS
  • National Institutes of Health

Zitieren

APA

Issa, N. P., Aydin, S., Polley, E., Carberry, N., Garret, M. A., Smith, S., Habib, A. A., Baumgartner, N. W., Soliven, B., & Rezania, K. (2024). Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLOS ONE. https://doi.org/10.1371/journal.pone.0303053

Vancouver

Issa NP, Aydin S, Polley E, Carberry N, Garret MA, Smith S, et al. Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLOS ONE. 2024. doi:10.1371/journal.pone.0303053

BibTeX
@article{Issa2024,
  author = {Issa, Naoum P and Aydin, Serdar and Polley, Eric and Carberry, Nathan and Garret, Mark A and Smith, Sean and Habib, Ali A and Baumgartner, Nicholas W and Soliven, Betty and Rezania, Kourosh},
  title = {Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0303053}
}
Kostenlos starten →